BREAKING NEWS: Reversing Years of Expansion, Utah’s Myriad Genetics will Sell its Prenatal Testing Business for $210 Million in Cash to Labcorp
EXECUTIVE SUMMARY
✅ Myriad Genetics has agreed to sell its prenatal genetic-testing business to Labcorp for $210 million in cash, plus inventory, divesting an operation responsible for over 20% of its first-half 2026 revenue.
✅ The sale follows declining testing revenue, a $43.2 million second-quarter net loss, and
